Performance of GERN Geron | 123.1% in 12m
Compare GERN with Indices, Sectors and Commodities ✔ like Oil, Gas, Gold, Yields and Bonds. Who outperforms?
Compare Geron with its related Sector/Index XBI
Performance Duell GERN vs XBI
| TimeFrame | GERN | XBI |
|---|---|---|
| 1 Week | -6.24% | 3.20% |
| 1 Month | -10.8% | -1.62% |
| 3 Months | -14.7% | -0.49% |
| 6 Months | 10.3% | 17.47% |
| 12 Months | 123.1% | 48.62% |
| YTD | 89.7% | 10.21% |
| Rel. Perf. 1m | -0.74 | |
| Rel. Perf. 3m | -0.22 | |
| Rel. Perf. 6m | -0.47 | |
| Rel. Perf. 12m | 4.10 | |
| Spearman 1m | -0.82 | -0.143 |
| Spearman 3m | -0.60 | -0.010 |
Is Geron a good stock to buy?
Yes. Based on ValueRay Analyses, Geron (NASDAQ:GERN) is currently (October 2024)
a good stock to buy. It has a ValueRay Growth Rating of 70.80 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GERN as of October 2024 is 4.66. This means that GERN is currently undervalued and has a potential upside of +14.78% (Margin of Safety).
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of GERN as of October 2024 is 4.66. This means that GERN is currently undervalued and has a potential upside of +14.78% (Margin of Safety).
Is GERN a buy, sell or hold?
- Strong Buy: 4
- Buy: 3
- Hold: 0
- Sell: 0
- Strong Sell: 0
Values above 0%: GERN is performing better - Values below 0%: GERN is underperforming
Compare GERN with Broad Market Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -7.32% | -14.51% | -6.75% | 82.95% |
| US NASDAQ 100 | QQQ | -5.97% | -14.67% | -5.38% | 83.59% |
| US Dow Jones Industrial 30 | DIA | -8.07% | -14.72% | -5.22% | 90.23% |
| German DAX 40 | DBXD | -7.22% | -15.11% | 1.29% | 93.19% |
| UK FTSE 100 | ISFU | -6.73% | -10.05% | -3.17% | 98.88% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 2.19% | -27.70% | 1.99% | 111.74% |
| Hongkong Hang Seng | HSI | -1.31% | -19.86% | -13.52% | 112.01% |
| Japan Nikkei 225 | EXX7 | -5.79% | -14.92% | 7.11% | 100.11% |
| India NIFTY 50 | INDA | -4.91% | -7.97% | -0.21% | 94.98% |
| Brasil Bovespa | EWZ | -5.82% | -4.84% | 13.12% | 121.65% |
GERN Geron vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -7.08% | -14.25% | -3.57% | 85.46% |
| Consumer Discretionary | XLY | -6.90% | -13.88% | -5.48% | 90.99% |
| Consumer Staples | XLP | -7.31% | -9.61% | -2.94% | 97.67% |
| Energy | XLE | -4.51% | -14.93% | 12.46% | 119.20% |
| Financial | XLF | -10.58% | -16.18% | -10.54% | 72.80% |
| Health Care | XLV | -5.99% | -9.06% | -0.59% | 102.20% |
| Industrial | XLI | -8.34% | -16.33% | -5.09% | 80.24% |
| Materials | XLB | -8.31% | -14.98% | 0.06% | 91.37% |
| Real Estate | XLRE | -9.59% | -10.20% | -16.16% | 82.66% |
| Technology | XLK | -6.10% | -15.94% | -5.79% | 81.69% |
| Utilities | XLU | -9.96% | -14.50% | -18.72% | 78.05% |
| Aerospace & Defense | XAR | -10.00% | -17.77% | -13.28% | 80.23% |
| Biotech | XBI | -9.44% | -9.15% | -7.14% | 74.46% |
| Homebuilder | XHB | -9.60% | -12.93% | -13.38% | 46.50% |
| Retail | XRT | -10.70% | -13.52% | -1.11% | 89.27% |
Does Geron outperform its market, is GERN a Sector Leader?
Yes, over the last 12 months Geron (GERN) made 123.08%, while its related Sector, the SPDR S&P Biotech (XBI) made 48.62%.
Over the last 3 months GERN made -14.71%, while XBI made -0.49%.
Yes, over the last 12 months Geron (GERN) made 123.08%, while its related Sector, the SPDR S&P Biotech (XBI) made 48.62%.
Over the last 3 months GERN made -14.71%, while XBI made -0.49%.
| Period | GERN | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -10.77% | -1.62% | 3.74% |
| 3 Months | -14.71% | -0.49% | 4.88% |
| 12 Months | 123.08% | 48.62% | 40.13% |